Waters Corporation (Milford, Massachusetts) has announced that it has completed its previously disclosed combination with the Biosciences and Diagnostic Solutions businesses of Becton, Dickinson and ...

Waters Corporation (NYSE: WAT) ("Waters") today announced it has completed the previously announced combination with the ...

FDA proposes MRD-negative and complete response endpoints to fast-track multiple myeloma drug approvals, pushing deeper molecular results over ORR.

Artificial intelligence (AI) is now an essential tool in biopharma manufacturing, yet industry still needs guidelines on how LLMs, ML, and other technologies should be used in drug making, say the ...

Diamond quantum nanoprobes detect immune cell inflammation by sensing electric charge shifts, opening a new path for ...

Q4 2025 Earnings Call February 9, 2026 8:30 AM ESTCompany ParticipantsCaspar Tudor - Head of Investor RelationsUdit Batra ...

Announces appointment of Claire M. Fraser, Ph.D., to its Board of DirectorsForms a global life sciences and diagnostics leader focused on high-volume testing in regulated applicationsAnnounces ...

Researchers are preparing for the arrival of a new state‑of‑the‑art instrument that will accelerate studies into some of the ...

Nonresponse to bridging therapy and high lymphocyte count were predictive of parkinsonism and nonrelapse mortality (NRM) after treatment with ciltacabtagene autoleucel (cilta-cel; Carvykti) in ...

Join leading experts at the analytica conference, showcasing advancements in analytical chemistry, bioanalytics, and ...

As Cytek Biosciences navigates its regulatory quiet period, the investment community is looking ahead to the imminent release of its complete fourth-quarter and ...

In this prospective cohort study, CD19-directed chimeric antigen receptor (CAR) T-cell therapy was found to elicit a complete ...